NASDAQ
HCTI
Last Price
US $1.73
KEY FIGURES
MKT CAP
$2.0M
EPS
TTM
$-6068.09
EPS Growth (1Y)
-9.39%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
-
YIELD
-
GROWTH (5Y CAGR)
Profit margin
Current Ratio
Capital Returns
-56.46%
Return on equity
ROIC: -21.87%
Valuation History
-
Price to Earnings
EV/EBITDA: -0.88X
Cash flow
Profit margin
Revenue
-15.02%
EBITDA
-
Cash flow
-46.35%
Cash Flow (DCF)
Fair Value
Market $1.73
—
Default assumptions
EBITDA Multiple
Fair Value
Market $1.73
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Cash flow to debt coverage
Healthcare Triangle, Inc. cash flow to debt ratio of -153.89% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Healthcare Triangle, Inc.'s free cash flow has decreased 1.43K% from $-1.08M last year to $-16.52M, signaling decreasing performance
Debt-to-equity ratio
Healthcare Triangle, Inc.'s debt to equity ratio is 0.21, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Healthcare Triangle, Inc.'s debt has increased relative to shareholder equity from -0.52 last year to 0.21 today, signaling weakened financials
Net debt to EBITDA
Healthcare Triangle, Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
Healthcare Triangle, Inc.'s interest coverage ratio is -50.48, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Healthcare Triangle, Inc.'s profit margin has decreased (36.62%) in the last year from -51.03% to -69.72%, signaling decreasing performance
Current ratio
Healthcare Triangle, Inc.'s short-term assets of $13.15M exceed its short-term liabilities of $12.79M
Return on assets
Healthcare Triangle, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Healthcare Triangle, Inc.'s return on equity of -68.42%, is lower than 15.00%, indicating bad performance
Earnings quality
Healthcare Triangle, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Healthcare Triangle, Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Healthcare Triangle, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Healthcare Triangle, Inc. has negative free cash flow, indicating cash burn
Earnings growth
Healthcare Triangle, Inc.'s yearly earnings has decreased 58.75% since last year from $-5.97M to $-9.48M, signaling decreasing performance
Revenue growth
Healthcare Triangle, Inc.'s yearly revenue has increased 18.77% since last year from $11.70M to $13.89M, signaling increasing performance
Return on invested capital
ROIC -17.48% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Healthcare Triangle, Inc.'s 3-year revenue CAGR of -32.85% is negative, indicating declining revenue over the past 3 years
Revenue consistency
Healthcare Triangle, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Healthcare Triangle, Inc. has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Healthcare Triangle, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Healthcare Triangle, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Healthcare Triangle, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Healthcare Triangle, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Healthcare Triangle, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Healthcare Triangle, Inc. has a price-to-book ratio of 0.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Healthcare Triangle, Inc. has a price-to-sales ratio of 0.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue